Iftikhar Mustafa, Hsu S Tammy, Vajzovic Lejla, Hadziahmetovic Majda
Duke Eye Center, Duke University School of Medicine, Durham, NC, USA.
J Vitreoretin Dis. 2024 Dec 7:24741264241305103. doi: 10.1177/24741264241305103.
To present the management and outcomes of a case of acute submacular hemorrhage due to neovascular age-related macular degeneration (nAMD). A single case was retrospectively evaluated. A 79-year-old man with a history of submacular hemorrhage from nAMD and persistent disease activity in the left eye presented with acute submacular hemorrhage in his better-seeing right eye, which was previously closely monitored for an extrafoveal serous pigment epithelial detachment without exudation. The patient received intravitreal antivascular endothelial growth factor (anti-VEGF) and subsequently had pars plana vitrectomy with subretinal tissue plasminogen activator and gas tamponade. After 5 days of face-down positioning, the hemorrhage was successfully displaced from the fovea. Recurrent disease activity 2 weeks postoperatively prompted intensive biweekly anti-VEGF therapy. By postoperative month 5, the patient's visual acuity improved from 20/400 to 20/70 OD. This case highlights the importance of close monitoring of patients with nAMD exhibiting aggressive disease as well as the efficacy of prompt surgical intervention and increased anti-VEGF frequency for large submacular hemorrhages.
介绍一例因新生血管性年龄相关性黄斑变性(nAMD)导致的急性黄斑下出血的治疗及预后情况。对一例患者进行回顾性评估。一名79岁男性,有左眼nAMD所致黄斑下出血病史且疾病持续活动,其视力较好的右眼出现急性黄斑下出血,该右眼之前因无渗出的黄斑外浆液性色素上皮脱离而受到密切监测。患者接受了玻璃体腔内抗血管内皮生长因子(抗VEGF)治疗,随后行玻璃体视网膜手术,术中使用视网膜下组织纤溶酶原激活剂并进行气体填塞。面朝下体位5天后,出血成功从黄斑中心凹移位。术后2周疾病复发活动促使每两周进行一次强化抗VEGF治疗。术后第5个月,患者右眼视力从20/400提高到20/70。该病例强调了对表现为侵袭性疾病的nAMD患者进行密切监测的重要性,以及对大量黄斑下出血进行及时手术干预和增加抗VEGF治疗频率的有效性。